UPDATE: TG Therapeutics (TGTX) Secures Grant from National Multiple Sclerosis Society to Support Development of TGR-1202 (Umbralisib) as Oral B-cell Targeted Treatment Option
Tweet Send to a Friend
(Updated - September 29, 2017 7:33 AM EDT)
TG Therapeutics, Inc. (NASDAQ: TGTX) announced today that it has entered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
TG Therapeutics, Inc. (NASDAQ: TGTX) announced today that it has entered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
